Tanzania’s First Line of Defense Against Pandemics: Neema Vulugu

A Year in Review: 2022

World Economic Forum: Ending Tuberculosis: How Do We Get There?

02 February 2023

Global Fund Praises Luxembourg’s Additional Pledge, Bringing Total Contribution to €14.7 million
01 February 2023

African Leaders Unite in Pledge to End AIDS in Children
18 January 2023

2023-2025 Allocations Now Available
08 December 2022

Updated Resources for the Next Funding Cycle
08 December 2022

Grant-making for the Next Funding Cycle
08 December 2022

Updates on the Protection from Sexual Exploitation, Abuse and Harassment (PSEAH)

The Global Fund invests US$4 billion a year to defeat HIV, TB and malaria and ensure a healthier, safer, equitable future for all.

We unite the world to find solutions that have the most impact, and we take them to scale worldwide. It’s working. We won’t stop until the job is finished.

Impact

lives saved through the Global Fund partnership

Results

HIV and AIDS

23.3

people on antiretroviral therapy for HIV in 2021

HIV and AIDS

Tuberculosis

5.3

people with TB treated in 2021

Tuberculosis

Malaria

133

mosquito nets distributed in 2021

Malaria

Stories Opinion Videos

2023-2025 Allocation Funding

Results Report 2022

Seventh Replenishment

Tanzania’s First Line of Defense Against Pandemics: Neema Vulugu

A Year in Review: 2022

World Economic Forum: Ending Tuberculosis: How Do We Get There?

The Global Fund invests US$4 billion a year to defeat HIV, TB and malaria and ensure a healthier, safer, equitable future for all.

Data Explorer Data on investments and results

Data Service API, reports and raw data

Digital Library Images and videos